Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association Endorsed by the American Society for Radiation Oncology

被引:135
作者
Levine, Glenn N. [1 ,2 ]
D'Amico, Anthony V. [3 ,4 ]
Berger, Peter [6 ]
Clark, Peter E. [7 ]
Eckel, Robert H. [8 ]
Keating, Nancy L. [5 ]
Milani, Richard V. [9 ]
Sagalowsky, Arthur I. [10 ]
Smith, Matthew R. [11 ]
Zakai, Neil [12 ]
机构
[1] Baylor Coll Med, Cardiol Sect, Houston, TX 77030 USA
[2] Michael E DeBakey VA Med Ctr, Cardiac Care Unit, Houston, TX USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dept Med, Dept Hlth Care Policy, Boston, MA USA
[6] Geisinger Hlth Syst, Danville, PA USA
[7] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[8] Univ Colorado, Div Endocrinol Metab & Diabet & Cardiol, Denver, CO 80202 USA
[9] Ochsner Hlth Syst, Dept Cardiovasc Dis, New Orleans, LA USA
[10] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[11] Massachusetts Gen Hosp, Genitourinary Unit Oncol, Boston, MA 02114 USA
[12] Univ Vermont, Burlington, VT USA
关键词
HORMONE AGONIST TREATMENT; BONE-MINERAL DENSITY; LEAN BODY-MASS; SUPPRESSION THERAPY; ARTERIAL STIFFNESS; FOLLOW-UP; DISEASE; MEN; RADIOTHERAPY; MORTALITY;
D O I
10.3322/caac.20061
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:194 / 201
页数:8
相关论文
共 45 条
[31]   Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: Long-term results of RTOG 8610 [J].
Roach, Mack, III ;
Bae, Kyounghwa ;
Speight, Joycelyn ;
Wolkov, Harvey B. ;
Rubin, Phillip ;
Lee, R. Jeffrey ;
Lawton, Colleen ;
Valicenti, Richard ;
Grignon, David ;
Pilepich, Miljenko V. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :585-591
[32]   Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer [J].
Saigal, Christopher S. ;
Gore, John L. ;
Krupski, Tracey L. ;
Hanley, Janet ;
Schonlau, Matthias ;
Litwin, Mark S. .
CANCER, 2007, 110 (07) :1493-1500
[33]   The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer [J].
Smith, JC ;
Bennett, S ;
Evans, LM ;
Kynaston, HG ;
Parmar, M ;
Mason, MD ;
Cockcroft, JR ;
Scanlon, MF ;
Davies, JS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (09) :4261-4267
[34]   Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer - Differences from the classic metabolic syndrome [J].
Smith, Matthew R. ;
Lee, Hang ;
McGovern, Francis ;
Fallon, Mary Anne ;
Goode, Melissa ;
Zietman, Anthony L. ;
Finkelstein, Joel S. .
CANCER, 2008, 112 (10) :2188-2194
[35]   Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer [J].
Smith, Matthew R. ;
Lee, Hang ;
Fallon, Mary Anne ;
Nathan, David M. .
UROLOGY, 2008, 71 (02) :318-322
[36]   Insulin sensitivity during combined androgen blockade for prostate cancer [J].
Smith, MR ;
Lee, H ;
Nathan, DM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (04) :1305-1308
[37]   Changes in body composition during androgen deprivation therapy for prostate cancer [J].
Smith, MR ;
Finkelstein, JS ;
McGovern, FJ ;
Zietman, AL ;
Fallon, MA ;
Schoenfeld, DA ;
Kantoff, PW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02) :599-603
[38]   Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer [J].
Smith, MR .
UROLOGY, 2004, 63 (04) :742-745
[39]   AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update [J].
Smith, Sidney C., Jr. ;
Allen, Jerilyn ;
Blair, Steven N. ;
Bonow, Robert O. ;
Brass, Lawrence M. ;
Fonarow, Gregg C. ;
Grundy, Scott M. ;
Hiratzka, Loren ;
Jones, Daniel ;
Krumholz, Harlan M. ;
Mosca, Lori ;
Pasternak, Richard C. ;
Pearson, Thomas ;
Pfeffer, Marc A. ;
Taubert, Kathryn A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (10) :2130-2139
[40]   Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European organisation for research and treatment of cancer (EORTC) trial 30891 [J].
Studer, UE ;
Whelan, P ;
Albrecht, W ;
Casselman, J ;
de Reijke, T ;
Hauri, D ;
Loidl, W ;
Isorna, S ;
Sundaram, SK ;
Debois, M ;
Collete, L .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) :1868-1876